Phase 2 TRIO Clinical Trials
24 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 24 trials
Recruiting
Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Recurrent Endometrial CarcinomaEndometrial AdenocarcinomaEndometrial Clear Cell Adenocarcinoma+6 more
National Cancer Institute (NCI)81 enrolled137 locationsNCT05112601
Recruiting
Phase 2
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Endometriosis
Gesynta Pharma AB190 enrolled41 locationsNCT07260669
Recruiting
Phase 2
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
Endometrioid Endometrial Adenocarcinoma
University of Florida20 enrolled1 locationNCT07107334
Recruiting
Phase 1Phase 2
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Recurrent Ovarian CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma+13 more
Mayo Clinic40 enrolled3 locationsNCT05920798
Recruiting
Phase 2
Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
Endometriosis
Mclean Hospital30 enrolled1 locationNCT06477406
Recruiting
Phase 2
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion
Recurrent Ovarian CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma+12 more
Roswell Park Cancer Institute60 enrolled1 locationNCT04919629
Recruiting
Phase 2
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
Platinum-Sensitive Ovarian CarcinomaRecurrent Ovarian CarcinomaRecurrent Fallopian Tube Carcinoma+12 more
Roswell Park Cancer Institute80 enrolled2 locationsNCT05231122
Recruiting
Phase 2
Glycemic Regulation as Endometriosis Adjunct Treatment
EndometriosisPelvic Pain
Boston Children's Hospital14 enrolled1 locationNCT06611501
Recruiting
Phase 2Phase 3
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
EndometriosisInfertility, FemaleAdenomyosis
Hopital Foch180 enrolled1 locationNCT04356664
Recruiting
Phase 2
Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
Endometriosis
University of North Carolina, Chapel Hill24 enrolled1 locationNCT05480995
Recruiting
Phase 2
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Endometrioid Ovarian CancerFallopian Tube CancerEpithelial Ovarian Cancer+1 more
TORL Biotherapeutics, LLC230 enrolled66 locationsNCT06690775
Recruiting
Phase 2
Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
Endometrioid Endometrial Cancer
Women's Hospital School Of Medicine Zhejiang University39 enrolled1 locationNCT06561308
Recruiting
Phase 2
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Endometrial CancerCancerTumor+3 more
Aadi Bioscience, Inc.29 enrolled9 locationsNCT05997017
Recruiting
Phase 2
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
Cervical CancerSolid TumorHigh Grade Serous Ovarian Cancer+2 more
University of Oklahoma55 enrolled4 locationsNCT05512208
Recruiting
Phase 2
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Advanced Ovarian CarcinomaAdvanced Fallopian Tube CarcinomaAdvanced Primary Peritoneal Carcinoma+15 more
Mayo Clinic78 enrolled3 locationsNCT06639074
Recruiting
Phase 2
A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
Endometriosis-related Pain
Changchun GeneScience Pharmaceutical Co., Ltd.200 enrolled1 locationNCT06963177
Recruiting
Phase 2
Oral-ATO for TP53-mutated Myeloid Malignancies
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Neoplasm+2 more
The University of Hong Kong30 enrolled1 locationNCT06778187
Recruiting
Phase 2
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
Mmr DeficiencyImmune-related Adverse EventEndometrial Cancer Stage I+1 more
Queensland Centre for Gynaecological Cancer10 enrolled3 locationsNCT06278857
Recruiting
Phase 2
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer
Ovarian CancerFallopian Tube CancerOvary Cancer+4 more
University College, London80 enrolled1 locationNCT05080556
Recruiting
Phase 2Phase 3
Medicinal cannabis for endometriosis: The EndoCann Trial
Endometriosis
Western Sydney University126 enrolled1 locationACTRN12624000328572